A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
- 13 December 1991
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 254 (5038) , 1643-1647
- https://doi.org/10.1126/science.1840703
Abstract
Many human melanoma tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. A gene was identified that directed the expression of antigen MZ2-E on a human melanoma cell line. This gene shows no similarity to known sequences and belongs to a family of at least three genes. It is expressed by the original melanoma cells, other melanoma cell lines, and by some tumor cells of other histological types. No expression was observed in a panel of normal tissues. Antigen MZ2-E appears to be presented by HLA-A1; anti-MZ2-E CTLs of the original patient recognized two melanoma cell lines of other HLA-A1 patients that expressed the gene. Thus, precisely targeted immunotherapy directed against antigen MZ2-E could be provided to individuals identified by HLA typing and analysis of the RNA of a small tumor sample.Keywords
This publication has 17 references indexed in Scilit:
- The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.The Journal of Experimental Medicine, 1991
- Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.The Journal of Experimental Medicine, 1990
- Presence on a human melanoma of multiple antigens recognized by autologous CTLInternational Journal of Cancer, 1989
- Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cellsCell, 1989
- Clonal analysis of the cytolytic T-cell response to human tumorsImmunology Today, 1987
- Production of stable cytolytic T‐cell clones directed against autologous human melanomaInternational Journal of Cancer, 1987
- Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.The Journal of Experimental Medicine, 1983
- Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.The Journal of Experimental Medicine, 1983
- Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors.The Journal of Experimental Medicine, 1981
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.The Journal of Experimental Medicine, 1980